HemaSense is Improving patient outcomes and reducing costs of percutaneous interventions by providing healthcare professionals the first early alert system for bleeding complications at the access site during post-op recovery. HemaSense is developing an access site monitor which is used during patient recovery to provide early detection and alert of subcutaneous bleeding events. The HemaSense monitor seamlessly integrates with existing patient recovery workflow and enables early, less costly interventions for patients when small amounts of blood are beginning to accumulate outside the femoral vessel.
| Website | http://www.hemasense.com |
| Employees | 5 (4 on RocketReach) |
| Founded | 2024 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Healthcare Technology, Post Operative Care, Surgical Recovery, Patient Monitoring, Medical Technology, Minimally Invasive Surgery, Patient Safety, Point Of Care Diagnostics, Cost Reduction Healthcare, Healthcare Solutions |
Looking for a particular HemaSense employee's phone or email?
Nathan Friedman is the CEO of HemaSense.
4 people are employed at HemaSense.